Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
70.2 CHF | -0.28% | -2.64% | +37.92% |
Jun. 18 | Switzerland's Cosmo Pharmaceuticals Receives Drug Registration Certificate for Lumeblue in China | MT |
Jun. 03 | Cosmo Pharmaceuticals Swings to Loss in FY23; Revenue Down | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.92% | 1.27B | |
+51.63% | 798B | |
+41.51% | 633B | |
-5.10% | 356B | |
+19.90% | 328B | |
+9.95% | 304B | |
+17.66% | 244B | |
+3.39% | 227B | |
+10.75% | 216B | |
+6.99% | 166B |
- Stock Market
- Equities
- COPN Stock
- News Cosmo Pharmaceuticals N.V.
- Cosmo Pharmaceuticals NV Announces License of Lumeblue EU Rights to Alfasigma